📈 69% of S&P 500 stocks beating the index - a historic record! Pick the best ones with AI.See top stocks

Standard Life fund arm raises governance concerns at VW, Shell

Published 03/02/2016, 08:45 AM
Updated 03/02/2016, 08:50 AM
© Reuters. A worker leaves the Standard Life House in Edinburgh, Scotland
SHEL
-
PFC
-
WPP
-
ABDN
-
AAL
-
TCGI
-
PHARP
-
GRI
-
BSX
-
EOG
-
0RYA
-
TEP
-
VOWG_p
-
4324
-

LONDON (Reuters) - The investment arm of British insurer Standard Life (L:SL) said on Wednesday it would step up its engagement with management at Volkswagen (DE:VOWG_P) and Royal Dutch Shell (L:RDSA) over certain concerns it has regarding corporate governance.

In its annual governance and stewardship report Standard Life Investments said it continued to be worried about a lack of independence on the German carmaker's supervisory board and board committees following the appointment of former Chief Financial Officer Hans Dieter Poetsche as chairman of the Supervisory Board, in the wake of the firm's emissions scandal.

The fund manager also said it continued to have concerns at Shell about the auditing of its accounts following the appointment of EY, which also served as auditor of BG, the company taken over by Shell last month.

Standard Life Investments flagged the two companies as candidates for "escalation", indicating the firm would press the companies on their concerns.

No one at Volkswagen could immediately be reached for comment, while Shell did not immediately respond to a request for comment.

In its report Standard Life Investments also said it had been influential in achieving governance changes at petroleum firm SOCO International (L:SIA), property manager Grainger (L:GRI) and oil producer EOG Resources (N:EOG).

© Reuters. A worker leaves the Standard Life House in Edinburgh, Scotland

It said budget airline Ryanair (L:RYA), advertising company WPP (L:WPP), oilfield services company Petrofac (L:PFC), utility services retailer Telecom Plus (L:TEP), miner Anglo American (L:AAL), tourism group Thomas Cook (L:TCG), heart device maker Boston Scientific (N:BSX) and advertising agency Dentsu (T:4324) were all on track to meet objectives concerning governance issues.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.